By Ferdous Al-Faruque - 05/23/14 01:35 PM EDT
The Senate Appropriations Committee has told the Food and Drug Administration to reach out to stakeholders such as physicians, patients and pharmacists before releasing new guidances for compounding pharmacies.
Under the 2013 Compounding Quality Act, the FDA has greater oversight and funding to regulate compounding pharmacies. However, the law also requires the agency to meet with stakeholders before issuing new guidances.
Under the 2013 Compounding Quality Act, the FDA has greater oversight and funding to regulate compounding pharmacies. However, the law also requires the agency to meet with stakeholders before issuing new guidances.
Read more: http://thehill.com/policy/healthcare/207108-fda-told-to-talk-before-enforcing-pharmacy-law#ixzz32Zq00Lw9
Follow us: @thehill on Twitter | TheHill on Facebook
No comments:
Post a Comment